Clinical Trial Update: Effect of Intravitreal Bevacizumab on Clinically Significant Macular Edema [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating intravitreal bevacizumab for clinically significant macular edema due to diabetic macular edema. The current status of …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• Bevacizumab (Avastin) (bevacizumab)

Snippet

Sponsor: Shahid Beheshti University of Medical Sciences | Conditions: Diabetic Macular Edema | Phase 3 | Status: UNKNOWN